Neuren Pharmaceuticals (ASX:NEU) Reports Record Financial Performance and Expansion Plans
Neuren Pharmaceuticals (ASX:NEU) reports a record A$166m income in 2024, driven by DAYBUE sales and initiates Phase 3 trials for NNZ-2591.
Tag: Dividends & Share Buybacks
BSP Financial Group Limited (ASX:BFL) Reports Strong 2024 Performance and Increases Dividend
BSP Financial Group Limited (ASX:BFL) announces strong 2024 financial results with a 16% dividend increase and ongoing modernization initiatives.
Restaurant Brands New Zealand Limited (ASX:RBD) Announces FY24 Financial Performance
Restaurant Brands New Zealand Limited (ASX:RBD) reports record FY24 sales, improved margins, and declares a special dividend for shareholders.
AFT Pharmaceuticals (ASX:AFP) Reports Record Annual Revenue
AFT Pharmaceuticals (ASX:AFP) reports a 6% increase in FY25 revenue, targets $300M by FY27, and declares an increased dividend.
Oceania Healthcare (ASX:OCA) Reports FY25 Results and Strategic Initiatives
Oceania Healthcare (ASX:OCA) reports FY25 results, highlighting financial performance and strategic initiatives for future growth.
Dicker Data (ASX:DDR) Releases FY24 Financial Results and Dividend Declaration
Dicker Data (ASX:DDR) releases FY24 results showing a 2.9% revenue increase and announces a final dividend of 11.0 cps.
Brisbane Broncos Limited (ASX:BBL) Announces 2024 Financial Results
Brisbane Broncos Limited (ASX:BBL) announces 2024 financial results, highlighting revenue growth, increased membership, and a final dividend declaration.
WCM Global Growth Limited (ASX:WQG) Declares Increased Dividend
WCM Global Growth Limited (ASX:WQG) declares a fully franked dividend of 1.89c per share for Q3 FY2025 and outlines a progressive dividend policy.
Aristocrat Leisure Limited (ASX:ALL) Announces Positive First Half Financial Results
Aristocrat Leisure Limited (ASX:ALL) reports a 9% revenue increase and returns $533M to shareholders in its H1 financial results.
Commonwealth Bank of Australia (ASX:CBA) Reports Earnings
Commonwealth Bank of Australia (ASX:CBA) reports a $2.6 billion NPAT for the half-year, highlighting strong financial performance and shareholder dividends.